Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Rational design of tumor microenvironment (TME)‐activated nanocomposites provides an
innovative strategy to construct responsive oncotherapy. In colorectal cancer (CRC), the …

Evidence implicating Eph receptor tyrosine kinases and their ephrin ligands (that together
make up the 'Eph system') in cancer development and progression has been accumulating …

Nanotechnology takes the lead in providing new therapeutic options for cancer patients. In
the last decades, lipid-based nanoparticles—solid lipid nanoparticles (SLNs) …

Amongst the various microtubule-targeting agents, Docetaxel (DTX) has gained immense
attention in cancer chemotherapy due to its good therapeutic index. DTX belongs to the …

According to a 2020 World Health Organization report (Globocan 2020), cancer was a
leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The aim …

The EphA2 receptor is found at high levels in tumors and low levels in normal tissue and
high EphA2 expression in biopsies is a predictor of poor outcome in patients. Drug discovery …

Drug encapsulated liposomes and monoclonal antibodies (Mabs) are two distinctively
different classes of therapeutics, but both aim to become the ultimate “magic bullet”. While …

Numerous prodrugs have been developed and used for cancer treatments to reduce side
effects and promote efficacy. In this work, we have developed a new photoactivatable …